Gain Therapeutics (GANX) Stock Chart & Stock Price History → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free GANX Stock Alerts $2.68 -0.22 (-7.59%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Gain Therapeutics Stock Price Performance5 Day Performance-4.39%1 Month Performance-17.49%3 Month Performance-41.53%6 Month Performance+1.07%Year-To-Date Performance-13.32%1 Year Performance-46.80% Receive GANX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him GANX Stock Chart for Wednesday, May, 8, 2024 GANX Chart by TradingView Gain Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$2.85$2.90+1.75%$3.14$2.78164,577 shs$52.35 million05/06/2024$2.96$2.85-3.72%$3.03$2.82131,742 shs$51.45 million05/03/2024$2.93$2.96+1.02%$3.02$2.8794,947 shs$53.43 million05/02/2024$2.97$2.93-1.35%$3.06$2.87121,216 shs$52.89 million05/01/2024$2.93$2.97+1.37%$3.05$2.9257,798 shs$53.61 million04/30/2024$3.00$2.93-2.33%$3.00$2.8934,753 shs$47.53 million Get the Latest News and Ratings for GANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$3.03$3.00-0.99%$3.03$2.8938,570 shs$48.66 million04/26/2024$3.07$3.03-1.30%$3.18$2.89179,297 shs$49.15 million04/25/2024$3.19$3.07-3.76%$3.20$2.95142,396 shs$49.80 million04/24/2024$3.39$3.19-5.90%$3.65$3.12146,812 shs$51.74 million04/23/2024$3.17$3.39+6.94%$3.39$3.0766,419 shs$54.99 million04/22/2024$3.18$3.17-0.31%$3.43$3.1253,675 shs$51.42 million04/19/2024$3.15$3.18+0.95%$3.23$3.0071,353 shs$51.58 million04/18/2024$3.18$3.15-0.94%$3.31$3.1178,261 shs$51.09 million04/17/2024$3.16$3.18+0.63%$3.27$3.1080,646 shs$51.58 million04/16/2024$3.09$3.16+2.27%$3.19$2.93111,460 shs$51.26 million04/15/2024$3.15$3.09-1.90%$3.23$3.0281,897 shs$50.12 million04/12/2024$3.36$3.15-6.25%$3.32$3.01123,743 shs$51.09 million04/11/2024$3.34$3.36+0.60%$3.41$3.2547,249 shs$54.50 million04/10/2024$3.38$3.34-1.18%$3.38$3.1079,471 shs$54.18 million04/09/2024$3.43$3.38-1.46%$3.53$3.3063,783 shs$54.82 million04/08/2024$3.56$3.43-3.65%$3.64$3.3175,270 shs$55.64 million04/05/2024$3.58$3.56-0.56%$3.72$3.49105,241 shs$57.74 million04/04/2024$3.99$3.58-10.28%$4.04$3.45177,370 shs$58.07 million04/03/2024$3.89$3.99+2.57%$4.04$3.7458,129 shs$64.72 million04/02/2024$3.83$3.89+1.57%$4.00$3.8292,050 shs$63.10 million04/01/2024$3.77$3.83+1.59%$4.00$3.57122,238 shs$62.12 million03/29/2024$3.77$3.77$3.95$3.68102,217 shs$61.15 million03/28/2024$3.73$3.77+1.07%$3.95$3.68102,211 shs$48.67 million03/27/2024$3.80$3.73-1.84%$3.90$3.60114,019 shs$48.15 million03/26/2024$3.65$3.80+4.11%$3.96$3.57145,671 shs$49.06 million03/25/2024$4.06$3.65-10.10%$4.10$3.55209,466 shs$47.12 million03/22/2024$4.37$4.06-7.09%$4.45$3.80246,566 shs$52.42 million03/21/2024$4.26$4.37+2.58%$4.63$4.21214,879 shs$56.42 million03/20/2024$4.25$4.26+0.24%$4.35$4.0978,321 shs$55.00 million03/19/2024$4.36$4.25-2.52%$4.38$4.2044,212 shs$54.87 million03/18/2024$4.29$4.36+1.63%$4.50$4.2570,799 shs$56.29 million03/15/2024$4.28$4.29+0.23%$4.43$4.22183,270 shs$55.38 million03/14/2024$4.54$4.28-5.73%$4.56$4.20145,820 shs$55.26 million03/13/2024$4.56$4.54-0.44%$4.65$4.3958,829 shs$58.61 millionREAD THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details.03/12/2024$4.67$4.56-2.36%$4.74$4.39104,016 shs$58.87 million03/11/2024$4.73$4.67-1.27%$4.74$4.6526,441 shs$60.29 million03/08/2024$4.60$4.73+2.83%$4.80$4.6444,774 shs$61.06 million03/07/2024$4.71$4.60-2.34%$4.75$4.5876,807 shs$59.39 million03/06/2024$4.66$4.71+1.07%$4.78$4.6069,784 shs$60.81 million03/05/2024$4.72$4.66-1.27%$4.79$4.17696,713 shs$60.16 million03/04/2024$4.68$4.72+0.85%$5.18$4.70348,173 shs$60.94 million03/01/2024$4.49$4.68+4.23%$4.70$4.52103,235 shs$60.42 million02/29/2024$4.46$4.49+0.67%$4.62$4.4462,893 shs$57.97 million02/28/2024$4.63$4.46-3.67%$4.80$4.4671,124 shs$57.58 million02/27/2024$4.50$4.63+2.89%$4.70$4.40104,662 shs$59.77 million02/26/2024$4.55$4.50-1.10%$4.75$4.4265,802 shs$58.10 million02/23/2024$4.44$4.55+2.48%$4.64$4.3661,302 shs$58.74 million02/22/2024$4.42$4.44+0.45%$4.50$4.10196,120 shs$57.32 million02/21/2024$4.67$4.42-5.35%$4.75$4.39128,219 shs$57.06 million02/20/2024$4.82$4.67-3.11%$4.89$4.6680,162 shs$60.29 million02/19/2024$4.82$4.82$4.92$4.6298,000 shs$62.23 million02/16/2024$4.80$4.82+0.42%$4.92$4.6298,035 shs$62.23 million02/15/2024$4.73$4.80+1.48%$4.91$4.65102,747 shs$61.97 million02/14/2024$4.51$4.73+4.88%$4.75$4.51141,216 shs$61.06 million02/13/2024$4.78$4.51-5.65%$4.84$4.50148,732 shs$58.22 million02/12/2024$5.04$4.78-5.16%$5.30$4.76232,120 shs$61.71 million02/09/2024$4.84$5.04+4.13%$5.30$4.94586,178 shs$65.07 million02/08/2024$4.75$4.84+1.89%$5.19$4.61575,598 shs$62.48 million02/07/2024$4.47$4.75+6.26%$5.33$4.391.45 million shs$61.32 million Related Companies: Aadi Bioscience Stock Price Chart Nabriva Therapeutics Stock Price Chart Checkpoint Therapeutics Stock Price Chart Rockwell Medical Stock Price Chart Equillium Stock Price Chart Bolt Biotherapeutics Stock Price Chart Immuneering Stock Price Chart HCW Biologics Stock Price Chart Eagle Pharmaceuticals Stock Price Chart BioLineRx Stock Price Chart Receive GANX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GANX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.